March 17, 2021
Adding SPRAVATO® as a service line can be profitable and provide life-saving treatments to patients who may not be able to afford other services.
However, administrative hurdles like REMS submissions and complex billing requirements can hinder the growth and profitability of your practice.
Osmind understands these challenges and is committed to simplifying SPRAVATO® administration and documentation, saving you hours on double documentation.
Osmind EHR offers a variety of features to support your practice when treating with SPRAVATO®, making the process more manageable, from Risk Evaluation and Mitgation Strategy (REMS) submissions to seamless charting.
The SPRAVATO Risk Evaluation and Mitigation Strategy (REMS) is an FDA-mandated program to ensure the safe use of esketamine (SPRAVATO®) by minimizing the risk of serious adverse outcomes resulting from sedation, dissociation, and abuse potential. The REMS program can be time-consuming, as it requires healthcare providers, patients, and pharmacies to enroll and comply with specific requirements.
Osmind EHR streamlines the SPRAVATO® REMS program by seamlessly integrating with it, automating documentation, and eliminating double data entry. This efficiency saves you time and reduces liability.
Osmind is the only private practice EHR in the country selected to work with Janssen to automate the submission of the Spravato REMS form directly from your clinical note, saving you time and effort.
To use this feature, select 'Spravato' from the Note Type dropdown when creating a clinical note.
When your note is created, you will see all of the REMS required fields highlighted in red.
Once the note is completed and all required fields have appropriate data, make sure to sign the note to generate the REMS form.
Signed forms will be sent automatically.
You can preview the form submitted from the patient's 'Documents' tab.
You can monitor the status of the submission also from the 'Documents' tab.